CA2062412A1 - Lowering blood cholesterol levels using water soluble cellulose ethers - Google Patents
Lowering blood cholesterol levels using water soluble cellulose ethersInfo
- Publication number
- CA2062412A1 CA2062412A1 CA002062412A CA2062412A CA2062412A1 CA 2062412 A1 CA2062412 A1 CA 2062412A1 CA 002062412 A CA002062412 A CA 002062412A CA 2062412 A CA2062412 A CA 2062412A CA 2062412 A1 CA2062412 A1 CA 2062412A1
- Authority
- CA
- Canada
- Prior art keywords
- water soluble
- soluble cellulose
- cellulose ethers
- cholesterol levels
- lowering blood
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
- A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
- A23L33/24—Cellulose or derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S426/00—Food or edible material: processes, compositions, and products
- Y10S426/804—Low calorie, low sodium or hypoallergic
Abstract
A method for reducing the cholesterol level in mammalian blood by administering a water soluble cellulose ether thereto. The cellulose ethers have a viscosity, measured as a 2% aqueous solution at 20°C, of at least about 35 cps. Oral administration is preferred, and, in one embodiment the high viscosity water soluble cellulose ether is hydroxypropyl methylcellulose, contained in a nutritious foodstuff.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US66639291A | 1991-03-08 | 1991-03-08 | |
US07/666,392 | 1991-03-08 | ||
US07/840,178 US5721221A (en) | 1991-03-08 | 1992-02-24 | Lowering blood cholesterol levels using water soluble cellulose ethers |
Publications (2)
Publication Number | Publication Date |
---|---|
CA2062412A1 true CA2062412A1 (en) | 1992-09-09 |
CA2062412C CA2062412C (en) | 2002-10-15 |
Family
ID=27099455
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002062412A Expired - Lifetime CA2062412C (en) | 1991-03-08 | 1992-03-06 | Lowering blood cholesterol levels using water soluble cellulose ethers |
Country Status (21)
Country | Link |
---|---|
US (2) | US5721221A (en) |
EP (1) | EP0503496B1 (en) |
JP (3) | JP3651894B2 (en) |
KR (1) | KR100216495B1 (en) |
AT (1) | ATE117555T1 (en) |
AU (1) | AU657301B2 (en) |
CA (1) | CA2062412C (en) |
DE (1) | DE69201255T2 (en) |
DK (1) | DK0503496T3 (en) |
ES (1) | ES2068623T3 (en) |
FI (1) | FI933893A0 (en) |
GR (1) | GR3015652T3 (en) |
HK (1) | HK1010036A1 (en) |
HU (1) | HUT65208A (en) |
IE (1) | IE67435B1 (en) |
IL (1) | IL101148A (en) |
MX (1) | MX9201014A (en) |
NO (1) | NO306284B1 (en) |
UA (1) | UA27782C2 (en) |
WO (1) | WO1992015313A1 (en) |
ZA (1) | ZA921691B (en) |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5281584A (en) * | 1992-02-28 | 1994-01-25 | The Dow Chemical Company | Effect of particle-size distribution of cellulose ethers on palatability of compositions |
US6458378B1 (en) | 1999-03-16 | 2002-10-01 | The Iams Company | Pet food composition for controlling postprandial glycemic response |
US5932258A (en) * | 1998-04-06 | 1999-08-03 | The Iams Company | Composition and process for improving glucose metabolism in companion animals |
US7001618B1 (en) | 1999-07-09 | 2006-02-21 | The Iams Company | Nutritional composition for weight management |
US6630159B2 (en) * | 1999-02-23 | 2003-10-07 | The Procter & Gamble Company | Limiting weight gain of cats by feeding carbohydrate source that excludes rice |
WO2003030916A1 (en) | 2001-10-12 | 2003-04-17 | Regents Of The University Of Minnesota | Medical and nutritional applications of highly refined cellulose |
US6899892B2 (en) * | 2001-12-19 | 2005-05-31 | Regents Of The University Of Minnesota | Methods to reduce body fat |
US6835558B2 (en) * | 2002-02-04 | 2004-12-28 | General Mills, Inc. | Beta-glucan compositions and process therefore |
CA2438025A1 (en) * | 2002-08-21 | 2004-02-21 | Advanced Nutri-Tech Systems Inc. | Fruit sponge |
TW200729300A (en) * | 2005-11-30 | 2007-08-01 | Nuflare Technology Inc | Film-forming method and film-forming equipment |
US20070123490A1 (en) * | 2005-11-30 | 2007-05-31 | Yokoyama Wallace H | Preventing or reducing oxidative stress or oxidative cell injury |
US20100247664A1 (en) * | 2006-10-20 | 2010-09-30 | Lynch Stephanie K | Method of preventing or treating metabolic syndrome |
US20090093442A1 (en) * | 2006-10-20 | 2009-04-09 | Lynch Stephanie K | Uses of water-soluble cellulose derivatives for preventing or treating metabolic syndrome |
JP4979735B2 (en) * | 2009-05-19 | 2012-07-18 | 信越化学工業株式会社 | Oil dough composition and method for producing oil dough composition |
JP2011087490A (en) * | 2009-10-21 | 2011-05-06 | Shin-Etsu Chemical Co Ltd | Meat additive, pickling liquid, and meat processed product |
JP2012217413A (en) * | 2011-04-12 | 2012-11-12 | Shin-Etsu Chemical Co Ltd | Foamable milk composition |
WO2013059065A1 (en) * | 2011-10-19 | 2013-04-25 | Dow Global Technologies Llc | Methods and compositions for inducing satiety |
JP6147268B2 (en) * | 2011-11-04 | 2017-06-14 | ロッテ精密化學株式会社LOTTE Fine Chemical Co.,Ltd. | Low fat mayonnaise composition and method for producing the same |
JP6235584B2 (en) * | 2012-07-17 | 2017-11-22 | ダウ グローバル テクノロジーズ エルエルシー | Solid dispersion containing highly substituted hydroxyalkylmethylcellulose |
ITFI20120268A1 (en) * | 2012-12-03 | 2014-06-04 | Diopeite Consulting Ltd | PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF OBESITY |
EP3256004A1 (en) | 2015-02-13 | 2017-12-20 | Mars, Incorporated | Pet food feeding system |
Family Cites Families (70)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2701782A (en) * | 1951-05-11 | 1955-02-08 | Upjohn Co | Method of making and aqueous suspension of methyl cellulose |
US2802741A (en) * | 1953-09-21 | 1957-08-13 | Dow Chemical Co | Cake mixes containing water-soluble cellulose ethers |
US2883327A (en) * | 1954-05-03 | 1959-04-21 | Upjohn Co | Reducing the gelation of methylcellulose by the addition of a neutral, water-soluble, amino carboxylic acid and product thereof |
US2831852A (en) * | 1954-05-27 | 1958-04-22 | Dow Chemical Co | Water-soluble thermoplastic cellulose ethers |
US3308020A (en) * | 1961-09-22 | 1967-03-07 | Merck & Co Inc | Compositions and method for binding bile acids in vivo including hypocholesteremics |
US3383281A (en) * | 1961-09-22 | 1968-05-14 | Merck & Co Inc | Method for binding bile acids in vivo |
US3342805A (en) * | 1964-05-27 | 1967-09-19 | Dow Chemical Co | Process for the manufacture of cellulose ethers |
US3499960A (en) * | 1965-01-25 | 1970-03-10 | Merck & Co Inc | Palatable coated particles of an anion exchange resin |
US3388082A (en) * | 1965-11-01 | 1968-06-11 | Dow Chemical Co | Novel hydroxypropyl methyl cellulose ethers, a process for preparing the same, and compositions utilizing such ethers |
US3627872A (en) * | 1968-04-08 | 1971-12-14 | Upjohn Co | Oral treatment of hyper-cholesteremia in mammals and birds with ether-type anion exchangers of polysaccharides |
US3721735A (en) * | 1970-07-15 | 1973-03-20 | C Thiffault | Compositions for and method of lowering cholesterol levels |
US3709876A (en) * | 1972-04-10 | 1973-01-09 | Dow Chemical Co | Water soluble hydroxyethyl methyl cellulose ether thickener for latex paint |
GB1506217A (en) * | 1975-08-26 | 1978-04-05 | Taiho Pharmaceutical Co Ltd | Oral antilipemic composition |
US4005195A (en) * | 1976-02-12 | 1977-01-25 | The Procter & Gamble Company | Compositions for treating hypercholesterolemia |
US4109018A (en) * | 1976-05-27 | 1978-08-22 | Thompson Jerome B | Low calorie diet bread |
US4265879A (en) * | 1977-09-13 | 1981-05-05 | Monsanto Company | Method for controlling blood triglycerides |
US4284649A (en) * | 1977-11-22 | 1981-08-18 | Wiczer Sol B | Thickened gelatinous edible alcoholic medicated carrier |
US4175124A (en) * | 1977-12-30 | 1979-11-20 | The Quaker Oats Company | Method of treating hypercholesterolemia |
GB2021948A (en) * | 1978-05-30 | 1979-12-12 | Speywood Lab Ltd | Water miscible gum composition and its preparation and use |
EP0005977A3 (en) * | 1978-05-30 | 1980-01-09 | The Speywood Laboratory Ltd. | Bread containing gum and its manufacture |
DK221879A (en) * | 1978-10-02 | 1980-04-03 | Sepywood Lab Ltd | RUBBER ITS MANUFACTURING AND USE |
US4251519A (en) * | 1979-07-30 | 1981-02-17 | Anheuser-Busch, Incorporated | Process for the prevention and reduction of elevated blood cholesterol and triglycerides levels |
US4362711A (en) * | 1980-07-11 | 1982-12-07 | Evreka Inc. | Blood cholesterol level reducing agent and method |
US4326523A (en) * | 1980-08-25 | 1982-04-27 | International Minerals & Chemical Corp. | Method of supplying micronutrients to animals |
US4432968A (en) * | 1980-10-20 | 1984-02-21 | The Dow Chemical Company | Weight control with fat imbibing polymers |
US4444761A (en) * | 1981-05-04 | 1984-04-24 | Syntex (U.S.A.) Inc. | Cellulose/carboxymethyl cellulose mixtures useful for controlling fecal output, and methods employing them |
JPS58135805A (en) * | 1982-02-08 | 1983-08-12 | Teijin Ltd | Powdery agent for coating and protecting nasal mucosa |
US4461782A (en) * | 1982-02-16 | 1984-07-24 | The Procter & Gamble Company | Low calorie baked products |
US4451490A (en) * | 1982-03-08 | 1984-05-29 | General Foods Corporation | High quality, reduced-calorie cake containing cellulose and process thereof |
US4389393A (en) * | 1982-03-26 | 1983-06-21 | Forest Laboratories, Inc. | Sustained release therapeutic compositions based on high molecular weight hydroxypropylmethylcellulose |
US4410693A (en) * | 1982-08-12 | 1983-10-18 | The Dow Chemical Company | Process for preparing cellulose derivatives |
US4923981A (en) * | 1982-09-03 | 1990-05-08 | Sbp, Inc. | Use of parenchymal cell cellulose to improve comestibles |
US4520017A (en) * | 1983-02-04 | 1985-05-28 | Tunc Deger C | Method of reducing nutrient absorption |
NZ207125A (en) * | 1983-02-17 | 1986-07-11 | Merrell Pharma Inc | Bulk laxative composition containing water-soluble cellulose ether |
JPS59155309A (en) * | 1983-02-22 | 1984-09-04 | Teijin Ltd | Active type vitamin d3 composition and its preparation |
US4477657A (en) * | 1983-07-08 | 1984-10-16 | The Dow Chemical Company | Process for preparing hydroxyalkylcellulose ethers |
JPS60142911A (en) * | 1983-12-29 | 1985-07-29 | Nippon Soda Co Ltd | Composition for use in oral cavity |
US4626287A (en) * | 1985-01-29 | 1986-12-02 | Merrell Dow Pharmaceuticals Inc. | Process for preparing sucrose encrusted methylcellulose particles for use in bulk laxative compositions |
US4614545A (en) * | 1985-08-15 | 1986-09-30 | The Dow Chemical Company | Hydroxypropyl methyl cellulose thickening agents for organic liquids |
SE458576B (en) * | 1985-06-20 | 1989-04-17 | Lejus Medical Ab | PROCEDURES FOR PREPARING A GUAR-GUM PRODUCT |
US4734285A (en) * | 1985-10-28 | 1988-03-29 | The Dow Chemical Company | Sustained release compositions |
US4704285A (en) * | 1985-11-18 | 1987-11-03 | The Dow Chemical Company | Sustained release compositions comprising hydroxypropyl cellulose ethers |
JPS62122671A (en) * | 1985-11-23 | 1987-06-03 | 千寿製薬株式会社 | Production of high viscous liquid for intraocular operation |
US4849227A (en) * | 1986-03-21 | 1989-07-18 | Eurasiam Laboratories, Inc. | Pharmaceutical compositions |
US4820813A (en) * | 1986-05-01 | 1989-04-11 | The Dow Chemical Company | Grinding process for high viscosity cellulose ethers |
JPH0657245B2 (en) * | 1986-05-14 | 1994-08-03 | ト−メ−産業株式会社 | Viscoelastic solution for ophthalmic surgery |
US4883788A (en) * | 1986-06-06 | 1989-11-28 | Hauser-Kuhrts, Inc. | Method and composition for reducing serum cholesterol |
DE3781051T2 (en) * | 1986-06-30 | 1993-03-04 | Terumo Corp | METHOD FOR PRODUCING A LOW-CALORIE CEREAL PRODUCT. |
GB8616669D0 (en) * | 1986-07-09 | 1986-08-13 | Merk Sharpe & Dohme Ltd | Pharmaceutical compositions |
US4895723A (en) * | 1986-09-08 | 1990-01-23 | Amer And Company | Cholestyramine compositions and method for preparation thereof |
US4789664A (en) * | 1986-12-19 | 1988-12-06 | The Procter & Gamble Company | Food compositions with superior blood cholesterol lowering properties |
CA1313135C (en) * | 1987-02-09 | 1993-01-26 | The Dow Chemical Company | Cholestyramine composition and process for its preparation |
US4849222A (en) * | 1987-03-24 | 1989-07-18 | The Procter & Gamble Company | Mixtures for treating hypercholesterolemia |
US4824675A (en) * | 1987-07-13 | 1989-04-25 | Alza Corporation | Dispenser with movable matrix comprising a plurality of tiny pills |
US4915954A (en) * | 1987-09-03 | 1990-04-10 | Alza Corporation | Dosage form for delivering a drug at two different rates |
US4950140A (en) * | 1987-09-14 | 1990-08-21 | The Procter & Gamble Company | Cookies containing psyllium |
EP0323666B1 (en) * | 1987-12-29 | 1992-03-25 | The Procter & Gamble Company | Mixed compositions for treating hypercholesterolemia |
US4959466A (en) * | 1988-01-25 | 1990-09-25 | Arco Chemical Technology, Inc. | Partially esterified polysaccharide (PEP) fat substitutes |
US4846889A (en) * | 1988-02-02 | 1989-07-11 | The Dow Chemical Company | Polymeric blend useful in thin-bed mortar compositions comprising a water-soluble cellulose ether and a water-insoluble, but water-dispersible polymer |
US4900573A (en) * | 1988-06-17 | 1990-02-13 | The Dow Chemical Company | Method of inhibiting oil adsorption in coated fried foods using hydroxypropyl methyl cellulose |
CA1331535C (en) * | 1988-10-03 | 1994-08-23 | Paul Dale Leis Jr. | Psyllium-containing products |
NZ232432A (en) * | 1989-02-10 | 1991-09-25 | Alko Ltd | Food compositions in which (some of) a high-energy ingredient is replaced by a degraded cellulose derivative with average molecular weight between 500 and 100000 |
FI895708A0 (en) * | 1989-02-10 | 1989-11-29 | Alko Ab Oy | VATTENLOESLIG SOENDERDELNINGSPRODUKT. |
US5268181A (en) * | 1989-04-13 | 1993-12-07 | Upsher-Smith Laboratories, Inc. | Method of using niacin to control nocturnal cholesterol synthesis |
US4996063A (en) * | 1989-06-30 | 1991-02-26 | The United States Of America, As Represented By The Secretary Of Agriculture | Method for making a soluble dietary fiber composition from oats |
US5219599A (en) * | 1990-02-23 | 1993-06-15 | Lipidyne Corporation | Artificial adipose |
US5213829A (en) * | 1990-02-23 | 1993-05-25 | Lipidyne Corporation | Meat products containing artificial edible adipose and methods of making |
US5130333A (en) * | 1990-10-19 | 1992-07-14 | E. R. Squibb & Sons, Inc. | Method for treating type II diabetes employing a cholesterol lowering drug |
WO1992015312A1 (en) * | 1991-03-01 | 1992-09-17 | University Of Michigan | Pharmaceutical compositions and uses of water-soluble, high-viscosity grade cellulose ethers |
US5281584A (en) * | 1992-02-28 | 1994-01-25 | The Dow Chemical Company | Effect of particle-size distribution of cellulose ethers on palatability of compositions |
-
1992
- 1992-02-24 US US07/840,178 patent/US5721221A/en not_active Expired - Lifetime
- 1992-02-28 UA UA93004309A patent/UA27782C2/en unknown
- 1992-02-28 HU HU9302531A patent/HUT65208A/en unknown
- 1992-02-28 JP JP50782992A patent/JP3651894B2/en not_active Expired - Lifetime
- 1992-02-28 WO PCT/US1992/001511 patent/WO1992015313A1/en active Search and Examination
- 1992-02-28 KR KR1019930702670A patent/KR100216495B1/en not_active IP Right Cessation
- 1992-03-05 IL IL10114892A patent/IL101148A/en not_active IP Right Cessation
- 1992-03-06 EP EP92103867A patent/EP0503496B1/en not_active Expired - Lifetime
- 1992-03-06 AT AT92103867T patent/ATE117555T1/en not_active IP Right Cessation
- 1992-03-06 ES ES92103867T patent/ES2068623T3/en not_active Expired - Lifetime
- 1992-03-06 DK DK92103867.5T patent/DK0503496T3/en active
- 1992-03-06 ZA ZA921691A patent/ZA921691B/en unknown
- 1992-03-06 AU AU11493/92A patent/AU657301B2/en not_active Ceased
- 1992-03-06 IE IE920730A patent/IE67435B1/en not_active IP Right Cessation
- 1992-03-06 CA CA002062412A patent/CA2062412C/en not_active Expired - Lifetime
- 1992-03-06 MX MX9201014A patent/MX9201014A/en not_active IP Right Cessation
- 1992-03-06 DE DE69201255T patent/DE69201255T2/en not_active Expired - Lifetime
-
1993
- 1993-08-31 NO NO933104A patent/NO306284B1/en not_active IP Right Cessation
- 1993-09-06 FI FI933893A patent/FI933893A0/en not_active Application Discontinuation
-
1995
- 1995-04-03 GR GR950400796T patent/GR3015652T3/en unknown
- 1995-05-19 US US08/445,407 patent/US5585366A/en not_active Expired - Lifetime
-
1998
- 1998-06-22 HK HK98105947A patent/HK1010036A1/en not_active IP Right Cessation
-
2002
- 2002-11-01 JP JP2002320120A patent/JP4116861B2/en not_active Expired - Lifetime
-
2007
- 2007-05-14 JP JP2007128679A patent/JP2007217424A/en not_active Withdrawn
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2062412A1 (en) | Lowering blood cholesterol levels using water soluble cellulose ethers | |
EP0399918A3 (en) | Preparation for blood dialysis and method for production thereof | |
MY108496A (en) | Hypoglycemic thiazolidine diones. | |
CA2198916A1 (en) | Delivery of solid drug compositions | |
AU7552687A (en) | Diphenyl-3-azahexane and diphenyl-4-azaheptane derivatives as cardiovascular agents | |
EP0141300A3 (en) | An occulusion compound of 2-nitroxymethyl-6-chloropyridine with beta-cyclodextrin and process for preparation thereof | |
AU669122B2 (en) | New pyrazine derivatives, their preparation and their use | |
IE35177B1 (en) | Improvements in or relating to uracil derivatives | |
ES8700145A1 (en) | A flavoured tablet having a high flavour intensity. | |
HU9202044D0 (en) | Method for producing 4-phenyl-piperidine-4-carbixamide derivatives and pharmaceutical preparatives containing these compounds as active agents | |
EP0294695A3 (en) | New polyoxygenated labdane derivatives, a process for their preparation, and their use as medicaments | |
GR890100833A (en) | Process for the preparation of a compound with gastric inhibitopy effect | |
IT1229502B (en) | COMPOSITIONS CONTAINING BISMUTO SUITABLE FOR THERAPEUTIC USE. | |
IL72234A (en) | Water-soluble 8-acylated rifampicin derivatives,their preparation and liquid pharmaceutical compositions containing them | |
GB1443892A (en) | Glazing compositions for baked farinaceous products | |
HUT59011A (en) | Process for producing composition, and its active ingredient, suitable for inactivating or removing harmful compounds in blood and other extracellular liquids | |
JPS577408A (en) | Pharmaceutical preparation of solid cytochrome c for oral administration | |
HUT73500A (en) | Use of benzydamine for producing pharmaceutical compositions for treatment of pathological conditions caused by tnf | |
IE812235L (en) | Preparation of completion fluid | |
GR3015480T3 (en) | p-Oxybenzoic acid derivatives, process for preparing them, and their use as medicaments. | |
KR860000073A (en) | Process for preparing an aqueous insulin formulation stabilized against mechanical stress | |
JPS5549381A (en) | 1-(3-hydroxypropyl)-3, 7-dimethylxanthine and its preparation | |
IE831267L (en) | Compostions containing salbutamol | |
UA36182A (en) | Method for correcting rheological disorders in patients with clinical manifestations of coronary atherosclerosis | |
JO1653B1 (en) | Benzimidazole process for its preparation |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
MKEX | Expiry |